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U.S.-Japan Joint Meeting on the
Toxicological Characterization of
Environmental Chemicals of Mutual
Interest*
by Terri Damstrat and Yuji Kurokawa*
The paper describes deliberations of a meeting between scientists from the U.S. National Toxicology
Program and the National Institute of Hygienic Sciences, Tokyo, Japan. The scientific approaches and
experimental processes used by each organization in designing, conducting, and evaluatingthe short-term
and long-term toxicity/carcinogenicity of environmental chemicals were evaluated.
Introduction
A joint meeting was held January 30 through Feb-
ruary 1, 1989, betweenscientistsfromtheU.S. National
Toxicology Program (NTP), Research Triangle Park,
NC, and the National Institute of Hygienic Sciences
(NIHS), Tokyo, Japan, to exchange information on the
scientific issues and processes involved in the design,
conduct, and evaluation of both short-term and long-
term toxicity/carcinogenicity studies.
As emphasized in the opening statements by Dr. Y.
Omori(NIHS) and Dr. D. P. Rall(NTP), countriesmust
work together in evaluating the toxicity of environ-
mentalchemicals inordertobetterprotectpublichealth
throughout the world. This cooperation will minimize
duplication of effort and will ensure better use offacil-
ities, staff, and funds, hence allowing more chemicals
to be evaluated more thoroughly.
Only a few of the 50,000 to 60,000 chemicals in com-
mon use have been studied adequately, and the world-
wideproduction ofsynthetic organicchemicals hasrisen
300-fold during the last four decades. Only by countries
working together can the number of chemicals evalu-
ated be increased. Experimental evidence in the field
of carcinogenesis coupled with epidemiological findings
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support the conceptthat results observed in laboratory
animals can be used to predict probable results for hu-
mans. All chemicals known to induce cancer in humans
that have been studied under adequate experimental
conditions also cause cancer in animals (1). An analysis
of the International Agency for Research on Cancer
(IARC) Information Bulletin on the Survey of Chemi-
cals BeingTested forCarcinogenicity (2), indicates that
approximately 1200 chemicals are currentlyundergoing
long-term chemical carcinogenicity studies in about 88
institutes in 20 countries. Ofthe studies listed, approx-
imately 315 were being conducted by the NTP and 55
by the NIHS. Formal presentations on experimental
programs to characterize chemical toxicity and carcin-
ogenicity by U.S. and Japanese participants were fol-
lowed by informal discussions. Brief summaries of the
presentations follow in the next sections.
U.S. National Toxicology Program
The NTP was established in 1978 by the Department
of Health and Human Services (DHHS) to coordinate
andintegratebothbasicandappliedtoxicologyresearch
and testing activities within DHHS. The Program is
mandated to: a) broaden the spectrum of toxicologic
information obtained on chemicals selected and evalu-
ated; b)increasethenumberofchemicalsandtoxicologic
end points evaluated, within resource limits; c) develop
and validate a series of assay methods and protocols
appropriate for regulatory needs; and d) communicate
the plans and results to governmental agencies, the
medical and scientific communities, and the public (3).
The NTP currently combines resources from three
agencies within DHHS including the Centers for Dis-
easeControl(NationalInstituteforOccupationalSafetyDAMSTRA AND KUROKAWA
and Health), Food and Drug Administration (National
Center for Toxicological Research), and the National
Institutes of Health (NIH). The National Institutes of
Health's National Cancer Institute (NCI) was a charter
member agency and remains active in the Program
through membership on the Executive Committee. The
NCI bioassay program was transferred to NIH in 1981.
Chemicals are selected for NTP toxicology and car-
cinogenesis study primarily because of potential wide-
spread human exposure and a lack ofadequate toxicity
data. Other selection criteria include the level of pro-
duction, uses, chemicalstructure, physicaland chemical
properties, and interest by research and regulatory
agencies. The chemicals evaluated are diverse with re-
spectto use andstructuralclasses, andincludenaturally
occurring (32%) and synthetic (68%) chemicals (4). De-
signing and conducting toxicologic experiments on such
diverse classes ofchemicals requires a flexible scientific
approach. Although NTP employs core protocols in
terms ofspecies, magnitude and number ofdose levels,
and duration of exposure (4), the toxicological infor-
mation sought on selected chemicals takes into account
a number of factors and involves a multidisciplinary
approach. Table 1 outlines the sequence ofevents from
chemical nomination to publishing results as technical
reports (4). Detailed descriptions of the varied pro-
cesses were presented and discussed at thejoint meet-
ing, and they can be found in several reports (4-10).
Only a few major features will be summarized in this
report.
Chemical Nomination and Selection
Nominations ofchemicals for toxicological evaluation
are submitted by member agencies ofthe NTP as well
as by other government agencies, industry, labor, and
the public. Literature summaries are prepared for each
chemical, and nominations are evaluated by the multi-
agency Chemical Evaluation Committee (CEC), which
recommends the types ofstudies to be considered with
a testing priority rating for each chemical.
The CEC recommendations are published for com-
ment in the Federal Register and are then reviewed by
the NTP Board ofScientific Counselors. Final decisions
on whether to continue with the evaluation or to delete
chemicals nominated for various types of experiments
are made by the NTP Executive Committee, composed
ofthe Directors ofthe U.S. Federalhealth researchand
regulatory agencies.
Toxicology Studies Design
Following Executive Committee action, each chemi-
cal is assigned to a staff scientist who evaluates the
available data and makes recommendations on experi-
mentaldesign. Allshort-term (14-day; 90-day) andlong-
tern (2-year) toxicity study designs are reviewed by
the NTP Toxicology Design Review Committee. This
committee, composed of NTP staff scientists with ex-
pertise in carcinogenesis, toxicology, pathology, statis-
tics, pharmacokinetics, genetics, animal care, and
Table 1. Chemical nomination to technical report issuance.
Identification of NTP
priority chemicals Pre-study phase In-life study phase Data analysis and interpretation
Chemical nomination Select toxicologist study Toxicology prechronic studies Statistical analyses
Public, industry, government manager (14-day, 90-day) Data interpretation and evaluation
Chemical Evaluation Committee Prepare health and safety Chemical disposition Draft technical report
FhederalRegisutermouncement document Genetic toxicology Multidisciplinary staffreview Feardera Riegtiste anounement Procure and analyze chemical Specialstudies Board of Scientific Counselors Board of scientific counselors Develop study design In-Life audits Peerreview of draft technical
Chemical selection Toxicology Design Committee Reviews and evaluation report review Executive Committee Federal Register announcement Necropsy Preparation and issuance of
Issue request for proposal Gross pathology technical report
Review proposals Histopathology
Select laboratory to perfonn Pathology quality assessment
study Pathology working group
Federal Register announcement
Develop study design for
toxicology and carcinogenesis
studies
Toxicology and carcinogenesis
studies (2-year and special
studies)
In-life audits
Review and evaluation
Necropsy
Gross pathology
Histopathology
Pathology quality assessment
Pathology working group
Data audits
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health and safety, evaluates and then approves ormod-
ifies the study design.
In some instances, a study is designed to focus on a
specific toxicological end point, but ordinarily the goal
is a comprehensive toxicological characterization ofthe
chemical including metabolism and disposition, genetic
toxicity, fertility and reproductive assessment, carcin-
ogenicity, and other toxic effects on specific target or-
gans (e.g., immune or nervous system). Toxicologic
characterization usually includes 14-day and 90 to 120
day studies, followed in many cases by 2-year studies.
Studies are performed under contract to the NTP by
qualifiedprivate laboratories orbyanothergovernment
agency or national laboratory. All of these studies are
carried out under Good Laboratory Practices (GLP).
Chemical Pathology
Since pathology data often provide the end point for
decisions concerningthepotentialhazardsofachemical,
it is essential that such data be accurate and reflect
currentknowledgeoflaboratoryanimalpathology. Both
qualitative and quantitative pathology diagnoses must
be considered. In typical 2-year carcinogenesis studies,
20,000 to40,000tissue sections aremade foreach chem-
ical studied in both sexes of rats and mice. When the
laboratory pathology evaluation is completed, the
slides, individual animal data, and pathology tables are
evaluated by an independent pathology quality assess-
ment laboratory.
The quality assessment report and representative
slides are subsequently reviewed by an ad hoc Pathol-
ogy Working Group (PWG) composed of experienced
members in rodent pathology, and the final diagnoses
represent a consensus of study laboratory, quality as-
sessment, and PWG pathologists (11). This procedure
has worked very successfully for the NTP and helps
assure that the pathology aspects ofthe study are con-
sistently evaluated.
Data Evaluation, Peer Review, and
Dissemination
The principal statistical methods employed in NTP
toxicology/carcinogenesis studies include survival
analysis and mortality-adjusted evaluation oftumor in-
cidence (12). Although the statistical significance of an
observed tumor increase is an important piece of evi-
dence used in the evaluation process, other issues such
as biologic significance, experimental design and con-
duct, falsepositives/falsenegatives, increasing/decreas-
ing trends in tumor incidence, and the use ofhistorical
controls are also considered. Rigid statistical rules are
not employed in the interpretation of carcinogenicity
data, and biological mechanisms are always considered.
Thequalityassuranceofdataisanintegralcomponent
of NTP toxicity/carcinogenicity studies. Good Labora-
tory Practices compliance inspections and in-life (and
retrospective) dataaudits are conducted in contractlab-
oratories. Noformalconclusions ortechnicalreportsare
issued until a retrospective audit has been completed.
The NTP uses the following five categories of evi-
dence ofcarcinogenic activity to summarize the results
observed in each experiment (male mice, female mice,
male rats, female rats).
a) Clear evidence ofcarcinogenicity is demonstrated
by studies that are interpreted as showinga dose-
related increase ofmalignant neoplasms, increase
of a combination of malignant and benign neo-
plasms, or marked increase of benign neoplasms
ifthere is an indication from this or other studies
of such tumors to progress to malignancy.
b) Some evidence ofcarcinogenicity is demonstrated
by studiesthat are interpreted as showingachem-
ically related increased incidence of neoplasms
(malignant, benign, or combined) in which the
strength ofthe response is less than that required
for clear evidence.
c) Equivocal evidence of carcinogenicity is demon-
strated by studies that are interpreted as showing
a marginal increase of neoplasms that may be
chemically related.
d) No evidence ofcarcinogenicity is demonstrated by
studies that are interpreted as showing no chem-
icallyrelatedincreasesinmalignantorbenignneo-
plasms.
e) Inadequate study of carcinogenicity is demon-
strated by studies that because of major qualita-
tive or quantitative limitations cannot be inter-
preted as valid for showing either the presence or
absence of a carcinogenic activity.
These categories refer to the strength of the experi-
mental evidence and not to carcinogenic potency or
mechanism.
Scientific peer review is a fundamental component of
the NTP program. Drafttechnicalreports summarizing
and evaluating the data on each chemical are peer-re-
viewed first by staff, then in public meetings by a Peer
ReviewPanelofexpertsinchemicalcarcinogenesis. The
recommendations of the reviewers and relevant com-
ments recorded at the meeting are incorporated in the
final revision of the Technical Reports. NTP actively
disseminates its reports both nationally and interna-
tionally.
National Institute of Hygienic
Sciences, Japan
The National Institute of Hygienic Sciences (NIHS)
was established in 1874 astheTokyoDrugControl Lab-
oratoryinTokyo. Itisthe oldestresearch Institutethat
belongs to the Ministry ofHealth and Welfare (MHW).
At the very beginning, the NIHS was principally en-
gaged in the inspection ofthe quality ofimported drugs
and of the chemicals in foods and water (including hot
springwater). However, with theincreasing concern of
the public over the safety ofa variety ofchemicals, the
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need for toxicological studies, in addition to physico-
chemical studies, became very apparent.
Under these circumstances, in 1978, an organization
called the Biological Safety Research Center (BSRC)
wasestablishedtogetherwithanewbuildingandanimal
facilities in the NIHS. The BSRC consists of four di-
visions, namely, Division of Toxicology (Head, Y. Ku-
rokawa), Division of Pharmacology (Head, A. Takan-
aka), Division of Pathology (Head, Y. Hayashi), and
Division ofMutagenesis (Head, M. Ishidate, Jr.) under
the Director of BSRC (M. Tobe). Approximately 60
professional staff and 20 professional technicians are
working at the BSRC. There are 13 other divisions in
the NIHS under the Director General (A. Tanimura)
and the Deputy Director General (M. Uchiyama) in ad-
dition to the Divisions ofthe BSRC.
Toxicological Studies at the BSRC
The BSRC conducts various toxicological studies as
a laboratory arm of the MHW, especially for the Min-
istry's Pharmaceutical Affairs Bureau and the Environ-
mental Health Bureau. High priority chemicals to be
studied at the BSRC are selected on the basis ofpublic
concern over human health. Usually the amount ofpro-
duction and use, biological and environmental effects,
and the quality and quantity of previous toxicological
data are considered before the final decision. The chem-
icals to be selected include medical drugs, food addi-
tives, agrochemicals, existing or new chemicals and
household chemicals which are regulated, respectively,
underthePharmaceutical Affairs Law, Food Sanitation
Law, Agricultural Chemical Regulation Law, Chemical
Substances ControlAct, andHouseholdChemicals Con-
trol Act. Also relevant are the Poisonous and Delete-
rious Substances Control Lawandthe Industrial Safety
and Health Law. GLP standards have been applied for
toxicity testing of medical drugs, agrochemicals, and
existing or new chemicals since the early 1980s. The
toxicity tests required for the safety evaluation ofeach
category of chemicals are shown in Table 2.
Sofar, approximately 900 chemicalsormixtureshave
been examined at the BSRC by various in vivo and/or
in vitro toxicological tests. The numbers of each test
conducted are listed in Table 3. A total of 453 in vivo
studies including 87 carcinogenicity tests has been con-
ducted mainly by feeding (42%) or by gavage (31%).
Others are by drinking, skin application, subcutaneous
injection, inhalation, etc. As to test species, the rat
(F344, Wistar, Sprague-Dawley) hasbeenthe most fre-
quent one used, followed by the mouse (B6C3F1, ddY),
rabbit, guineapig, monkey, dog, and hamster. On some
occasions, the tests required by the BSRC are con-
ducted at outside facilities (universities, local Public
Health Institutes, contract laboratories).
The test results obtained at the BSRC are submitted
to the MHW as a Final Report, and raw data are also
offered for further reference when required. The Final
Report is examined by the officials of responsible di-
visionsofthebureauandisusedasscientificbackground
data for their political management. Some ofthe Final
Reports are also opened fordiscussion atthe council for
drugs, food, and others to obtain expertopinions before
any final regulatory decision is made by the MHW.
Table 2. Toxicity tests and GLP in relation to chemical class and regulatory law.a
Household
Agro chemicals Chemicals chemicals
Drugs Food additives Agricultural Chemical Household
Pharmaceutical Food Chemical Substances Chemicals
affairs Law Sanitation Regulation Control Act Control Act
Regulatory law/test (1987) Law (1965) Law (1972) (1974) (1974)
-------------------------------------------------------------------- b
Acute R R R MBR ND
I--------------------------------------------------- - - -----J
Subacute R MBR R NR NR
Chronic R R R R ND
Reproduction NR R R R ND
Teratology R R R R ND
Dependence MBR NR NR NR NR
Antigenicity MBR NR R NR ND
Mutagenicity s MBR R R R ND
Carcinogenicity MBR MBR R R ND
Local irritation MBR NR R NR ND
28-day repeated NR NR NR Rc NR
Delayed neurotoxicity NR NR MBR NR NR
GLP R (1983) NR R (1984) R (1984) NR
aR, required; NR, not required; MBR, may be requested; ND, requirement not determined.
bPoisonous & Deleterious Substances Control Law (1965).
'Industrial Safety & Health Law (1972).
dScreening toxicity test.
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Table 3. Numbers oftoxicity tests conducted at the biological
safety research center (BSRC), NIHS since 1976.
Test Number
Acute toxicity 148
Subacute toxicity 40
Subchronic toxicity 72
Chronic toxicity 63
Carcinogenicity 87
Two-stage carcinogenesis 63
(skin, stomach, liver, kidney, pancreas)
Organ toxicity 25
(skin, kidney, lung, heart, eye)
ADME (absorption, distribution, metabolism, 49
excretion)
Teratogenicity 43
Multigeneration 3
Synergy 8
Allergy 3
Ames test 134a
Chromosome aberration test 781
Micronucleus test 46
aPositive tests only.
At the BSRC, the following 17 chemicals will be
tested or are being tested for chronic toxicity/carcino-
genicity using rats or mice:
dicofol cochineal
bis(tributyltin) oxide phytic acid
dipentene dimer capsaicin
1-cyanoguanidine tannic acid
1,1-bis(tert-butylperoxy)- tragacanth gum
3,3,5-trimethylcyclo- phloxine
hexane gardenian color (yellow)
5-chloro-2-methyl-4- carrageenan
isothiazolin-3-one
potassium pyrophosphate
sodium polyacrylic acid
aluminum potassium
sulfate
Also, mutagenicity and28-daytoxicitystudies arebeing
done on sevenchemicalsundertheChemicalSubstances
Control Act: nitrobenzene, dicyclopentadiene, diphen-
ylamine, pigment blue 15, chlorocyclohexane, pentaer-
ythritol, and benzene-1,2-decarboxylate diheptyl.
Chemical Substances Control Act
This law was adopted in Japan in 1973 to strictly
regulate chemicals that have properties of persistence
and bioaccumulation and potential chronic toxicological
effects that may be hazardous to humans. Until now,
nine chemicals have been designated by Cabinet order
as Specified Chemical Substances (i.e., PCB, PCN,
HCB, aldrin, dieldrin, endrin, DDT, chlordane andhep-
tachlor). However, in 1986 this law was revised to in-
clude chemicals that show properties ofpersistence but
relativelylowbioaccumulation (e.g., trichloroethylene).
The new concept follows: a) Chemicals that do not ac-
cumulate in bioorganisms but have persistence and the
potential to be harmful shall be designated as "Desig-
nated Chemical Substances," whose quantity ofmanu-
facture or import should be reported to the competent
authority. b) Anyone ofthe "Designated ChemicalSub-
stances" thatprovetothreaten environmentalpollution
and humanhealthbyapostmarketingsurveillance shall
be designated as a "Class-2 Specified Chemical Sub-
stances." c) The "Class-2 Specified Chemical Sub-
stances" shall be permitted formanufacture andimport
withinacertainquantityofthe"Class-2SpecifiedChem-
ical Substances" in question, ifit causes environmental
pollution and human health injury. d) "Specified Chem-
ical Substances" defined by the old Law correspond to
the "Class-1 Specified Chemical Substances" in the
amended Law. Accordingly, the biodegradability test
for persistence, n-octanol/water partition coefficient
test for bioaccumulation and mutagenicity tests (gene
mutation and chromosomal aberration) and 28-days re-
peated dose toxicity tests in animals as the screening
toxicity tests were adopted for new chemicals. On the
otherhand, so-called "Full-scale ToxicologyTests" that
are required mainly forexistingchemicals, chronic tox-
icity, carcinogenicity, reproduction, teratogenicity, tox-
icokinetics, mutagenicity tests invitro and invivo, and
pharmacological tests, are conducted. However, if a
chemical is not persistent, the bioaccumulation test or
the toxicity test shall not be required.
The revised law came into force on April, 1987, and
the SafetyEvaluationCommitteeoftheMHWhaseval-
uated 232 chemicals (204newand28existingchemicals)
to date. Amongthem, 32 chemicals havebeenclassified
as "Designated Chemical Substances" (Table 4). It
should be mentioned that as ofApril, 1989, trichloroe-
thylene, tetrachloroethylene, and carbon tetrachloride
have been designated as "Class-2 Specified Chemical
Substances" by the government.
Priority List Issued by the MHW
In 1988, aprioritylistconsistingof393chemicalswas
issued by the MHW for identifying candidate existing
chemicals for "Designated Chemical Substances." The
chemicals selected are those that have already been
determined by the Ministry ofInternational Trade and
Industry (MITI) to be persistent in the environment
and to have low bioaccumulative properties. They are
then divided into five groups, mainly based on toxicity
datatakenfromthe Registry ofToxic Effects ofChem-
icalSubstances and somefromtheU.S. NTP(chemicals
in group 1 have thehighest priority, and those in group
4 have the lowest priority). Chemicals in Group 5 are
those for which appropriate toxicity data are not avail-
able. Toxicitydataexaminedincludeoutcomesfromcar-
cinogenicity, mutagenicity, reproductive/develop-
mental toxicity, and general toxicity tests.
Priority List and Survey by the
Environmental Agency ofJapan
Since 1979theEnvironmentalAgencyofJapan(EAJ)
has been conducting a comprehensive survey of chem-
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Table 4. Designated chemical substances (since April, 1987).
Mutagenicity Animal
Chemical substances Ames Chromosome toxicology
Trichloroethylene + - +
Tetrachloroethylene - +
Carbon tetrachloride - +
Chloroform + _ +
1,2-Dichloroethane + + +
1,4-Dioxane - +
3,3'-Dichlorobenzidine + +
4,4'-Diamino-3,3'-dichlorodiphenylmethane + + +
2,4-Dichloro-3-methylphenola + +
Sodium 4-(2,4-dichloro-m-toluoyl)-1,3-dimethylpyrazol-5-olate - +
1,2-Dichloropropane + +
4-Methoxy-2,2',4'-trimethyldiphenylaminea - - +
Tributyltin methacrylate - - +
bis(Tributyltin) fumarate - - +
Tributltin fluoride - - +
bis(Tributyltin) 2,3-dibromosuccinate - - +
Tributyltin acetate - - +
Tributyltin laurate - - +
bis(Tributyltin) phathalate - - +
Alkyl(C = 8)acrylate-methyl methacrylatetributyltin metacrylate-copolymer - - +
2,2,3-Trichloro-3-phenyl-1,1-propanediol' - + +
N,N'-Ethylenbis (salicylideneaminate) copper (II)' - - +
Triphenyltin N,N-dimethyldithiocarbamate - - +
Triphenyltin fluoride - - +
Triphenyltin acetate - - +
Triphenyltin chloride - - +
Triphenyltin hydroxide - - +
Triphenyltin fatty acid (C = 9-10) ester - - +
Esterification product with 2-ethylhexanol at terminal carboxy groups of - - +
polycondensate (degree ofpolymerization: 1-100) of adipic acid*2-butyl-2-ethyl-1,3-
propane-diole1,6-hexanediola
4-Phenoxyphenola - + +
Epoxidized product of2,2-bis (hydroxymethyl)-1-butanol*1,2-epoxy-4-vinylcyclohexane - + +
adduct (degree of adduct: 1-700)a
Methyl 3,3-dimethyl-4-pentenoatea + +
aNew chemical substances (animal toxicology for 28 days).
icals in the environment, independent ofthe MHW. The
surveyis based ontheirownprioritylist, issued in 1978,
of 2000 existing chemicals, using the criteria of per-
sistence, bioaccumulation, and chronic toxicity. This
survey is conducted through the following three stages:
In the first stage chemicals expected to have a high
probability of persistence in the environment are se-
lected (ca. 50/year). In the second stage, an environ-
mental survey is conducted on these chemicals, and
those showing persistence in the environment are cho-
sen (ca. 5/year) for further evaluation. In the third
stage, chemicals that should be handled with care are
chosen from those persistent in the environment (1-2/
year), andwildlife monitoringwillbeconductedonthese
chemicals. In 1987 MITI issued the revised priority list
of 1145 chemicals, classified into 12 groups according to
their chemical structure. In this mannerthis survey has
been performed as a part of the safety check program
for existing chemicals which are not regulated by the
examination system ofthe Chemical Substances Control
Act.
Future Perspectives at the BSRC
The greater the increase in the numbers ofchemicals
inthe environment, themoretoxicity tests arerequired
for safety evaluation. Actually some of the tests that
would be conducted at the BSRC are transferred to
outside facilities when available because of the lack of
manpower, animal facilities, etc., at BSRC. Therefore
a movement toward establishing a new system regard-
ing chemical selection, toxicity testing, reporting, and
evaluation is now in progress. In short, it can be called
a modifiedJapanese-NTP, since the idea is very similar
to the existing and very active U.S. NTP.
Briefly, an Advisory Committee on the selection of
priority chemicals for testing will be organized at first.
When chemicals are nominated, the BSRC will deter-
mine the protocols for testing that will be conducted by
the contract laboratories that areunder strict GLPreg-
ulation. On the other hand, the BSRC will focus on
conducting further fundamental studies on the toxico-
logical mechanisms of chemicals that may have a high
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probability of affecting human health. The data from
the outside sources will be collected at the BSRC for
inspection by the Quality Assurance Unit and will then
be evaluated by the Peer Review Committee, which
consists ofthe BSRC staffas well as outside expertise.
In fact, a new division tentatively called the Division of
Comprehensive Evaluation will be responsible for the
overall processes ofthe new system; it is beingplanned
atthe BSRC and willbe started in the nearfuture. The
Final Report will be submitted to the MHW and then
published in the scientific journals as soon as possible
to be used by various organization in the world for
safety/risk assessment.
In conclusion, we believe that close communication
between NIEHS and the NIHS/BSRC is necessary to
exchange up-to-date toxicological information. Forthat
purpose, annual U.S.-Japan Joint Meetings by the
professional staff of the two institutes will be highly
beneficial.
Concluding Remarks
Dr. Y. Omori and Dr. D. P. Railnotedintheirclosing
remarks that the meeting had been very productive.
Through both formal presentations and informnal dis-
cussions, much information was exchanged about the
respective programs of the NIHS and the NTP. Par-
ticular emphasis was placed on the similarities and dif-
ferences in the approaches used by the two institutes.
It was evident that although differences in the govern-
mental organization and regulatory frameworks in each
countryresulted inunique national aspects (e.g., chem-
ical selection procedures), the NIHS and NTP share
many common objectives and methodologies in identi-
fying the potential toxicity of a large variety of chem-
icals. The two countries will continue theirjoint efforts
and avoid unnecessary duplication of effort. Priority
lists of chemicals have been and will continue to be
exchanged and examined in order to make recommen-
dations to the respective national governments and in-
ternational organizations on the need for toxicological
evaluations ofcertain chemicals. Futurejoint meetings
will continue to explore how best to implement collab-
orative efforts on the toxicological characterization of
environmental chemicals ofmutual interest.
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